Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

EDA-Supported Companies Work to Improve Quality of Life for Cardiac Patients

2/5/2016

0 Comments

 
Trenton, NJ ― As the country celebrates “National Wear Red Day®” to raise awareness about heart disease, @NJEDATech takes a look at several New Jersey Economic Development Authority (EDA)-supported companies that strive to improve the lives of cardiac patients.
 
According to the American Heart Association, heart disease and stroke cause one in three deaths among women each year, killing approximately one woman every 80 seconds.
 
“The statistics on heart disease are sobering,” EDA Chief Executive Officer Melissa Orsen said.  “However, the progress that EDA-supported startup companies are making toward stemming the tide of heart disease is promising.  From implantable medical devices to injectable drugs, these companies continue to create industry-leading, impactful products.”
​Svelte Medical Systems, located in New Providence, produces a cost-effective integrated balloon expandable drug eluting coronary stent system featuring the smallest diameter in the industry.
 
This stent, which is now approved in Europe and will undergo United States studies later this year, has led to a new standard of care in treating the buildup of plaque in coronary arteries, known as atherosclerosis. The company was founded by industry leading scientists -- physicist Dr. Robert Fischell and his sons Dr. David Fischell, also a physicist, and Dr. Tim Fischell, an interventional cardiologist.
 
The Fischells also founded Angel Medical Systems, located in Shrewsbury. The company developed an implantable device, known as the AngelMed Guardian® System that can detect the onset of a heart attack and alert patients to quickly seek medical attention.  The Guardian® is under final review for approval by the United States Food and Drug Administration this year.
 
Svelte Medical Systems and Angel Medical Systems are among the more than 500 companies that have benefitted from the State’s Technology Business Tax Certificate Transfer (NOL) Program.
 
The program allows qualified technology and biotechnology companies to sell unused New Jersey net operating losses and research and development tax credits to unrelated profitable corporations to raise cash to finance their growth and operations.
 
Svelte Medical Systems also raised millions of dollars from investors who took advantage of the State’s Angel Investor Tax Credit Program, which provides credits against New Jersey corporate business or gross income tax for 10 percent of a qualified investment in an emerging technology business that conducts research, manufacturing, or technology commercialization in the state.
 
VEESAG Mobile develops wearable technology aimed at helping people maintain their independence, remain healthier and live better. The company’s smart watch, Mobile Personal Emergency Response System (MPERSENS®), comes equipped with an application for heart monitoring and a one-touch emergency button, as well as location tracking, fall detection, and remote monitoring.
 
It can also share critical information with family members. Following confirmation in 2015 from Sprint and Verizon that the devices were compatible with their networks, VEESAG Mobile is ramping up manufacturing to make its watches widely available to consumers.
 
Ascendia Pharmaceuticals is developing ASD-002, an injectable form of the blood thinner clopidogrel, the generic form of Plavix®, which is currently administered orally. Ascendia expects ASD-002 to be utilized in multiple markets, including catheterization procedures, peripheral arterial disease and acute coronary syndrome. The company is currently preparing for clinical testing of ASD-002.
 
VEESAG Mobile and Ascendia Pharmaceuticals are both located at the EDA’s Commercialization Center for Innovative Technologies (CCIT). Nestled among commercial real estate up and down the Rt. 1 corridor in North Brunswick, CCIT is New Jersey’s leading life sciences incubator.
 
Home to nearly two dozen seed-stage life sciences companies, CCIT offers its tenants not only affordable lab and office space, but also a wealth of resources, such as assistance with identifying funding sources, including state incentives, and help making matches to private sector support, discounted rent for the first year for university spinouts, access to small business development resources and administrative support.
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608-2002
609-858-9507